Molecular Tumor Board: Translating Biology into Therapy

The idea of adapting cancer therapy to the specific molecular features of a tumor is changing the way we treat cancer, especially advanced cancer. Such features are discussed in a dedicated board (Molecular Tumor Board, MTB), in which experts from different fields (such as bioinformatics, molecular oncology, and molecular biology) work together with clinicians to select the best therapy for individual patients.

Learning goals:

1. Structure of the Molecular Tumor Board
2. Methods for comprehensive molecular analyses of tumor samples
3. Pathways exploited for therapies
4. Databases for the prioritization of molecular targets
5. Databases for the prioritization of molecular therapies
6. Selection of a therapy based on molecular aberrations

During the course, the participants will learn and practice various tools for analyzing and evaluating molecular aberrations. At the end of the workshop, the participants should be able to calculate targeted therapies for a patient themselves. The participants may also participate to the Molecular Tumor Board of the UCT Mainz (in German) or of Heidelberg (online, in English).

Teacher: PD Dr. Claudia Paret

Target: Clinician scientists, doctoral candidates, postdoctoral candidates

Next workshop: TBA

Maximum number of participants: 10

Technology: MS Teams

TransMed Credit Points: 1.2